Hospital Suppliers Show Vigor In ’07, With Prospects Strong For ’08 – Index
This article was originally published in The Gray Sheet
Executive Summary
Baxter and Becton Dickinson were among large-cap hospital supply firms to prove that boring can be beautiful in 2007, as med-tech investors turned off by volatility in the sexier cardiac implant sector turned on to the relative stability of diversified, low-risk hospital products with respectable growth
You may also be interested in...
Endeavor Stent’s Debut Drives 22% Growth In Medtronic Cardiovascular Biz
Medtronic's Endeavor zotarolimus-eluting coronary stent captured over 20% of the U.S. drug-eluting stent market by the tail end of the firm's fiscal fourth quarter (ended April 25), the company reported May 20
Endeavor Stent’s Debut Drives 22% Growth In Medtronic Cardiovascular Biz
Medtronic's Endeavor zotarolimus-eluting coronary stent captured over 20% of the U.S. drug-eluting stent market by the tail end of the firm's fiscal fourth quarter (ended April 25), the company reported May 20
Abbott’s Xience Stent Drives 35% Growth In Overseas Vascular Sales
Abbott continues to look forward to U.S. approval of its Xience V everolimus-eluting coronary stent by the end of June as European adoption of the device drives growth in its vascular unit